|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | |
| C07H 21/04 | |||
| A61K 48/00 | |||
| C12N 15/113 |
| (11) | Number of the document | 2640853 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11840796.4 |
| Date of filing the European patent application | 2011-11-17 | |
| (97) | Date of publication of the European application | 2013-09-25 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/061245 |
| Date | 2011-11-17 |
| (87) | Number | WO 2012/068405 |
| Date | 2012-05-24 |
| (30) | Number | Date | Country code |
| 414848 P | 2010-11-17 | US |
| (72) |
BENNETT, C., Frank, US
FREIER, Susan, M., US
MALLAJOSYULA, Jyothi, US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | MODULATION OF ALPHA SYNUCLEIN EXPRESSION |
| MODULATION OF ALPHA SYNUCLEIN EXPRESSION |